Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Statistics

Total Valuation

TPEX:3176 has a market cap or net worth of TWD 4.56 billion. The enterprise value is 6.64 billion.

Market Cap	4.56B
Enterprise Value	6.64B

Important Dates

The next estimated earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:3176 has 139.31 million shares outstanding. The number of shares has increased by 0.38% in one year.

Current Share Class	139.31M
Shares Outstanding	139.31M
Shares Change (YoY)	+0.38%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	11.12%
Owned by Institutions (%)	3.31%
Float	102.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.39
PB Ratio	0.97
P/TBV Ratio	3.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.11
EV / Sales	4.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.37

Financial Position

The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.36.

Current Ratio	5.41
Quick Ratio	4.34
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-9.09
Interest Coverage	-13.50

Financial Efficiency

Return on equity (ROE) is -9.52% and return on invested capital (ROIC) is -9.57%.

Return on Equity (ROE)	-9.52%
Return on Assets (ROA)	-2.96%
Return on Invested Capital (ROIC)	-9.57%
Return on Capital Employed (ROCE)	-5.16%
Weighted Average Cost of Capital (WACC)	4.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.20
Inventory Turnover	0.99

Taxes

In the past 12 months, TPEX:3176 has paid 73.81 million in taxes.

Income Tax	73.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.65% in the last 52 weeks. The beta is 0.28, so TPEX:3176's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+3.65%
50-Day Moving Average	33.02
200-Day Moving Average	31.11
Relative Strength Index (RSI)	45.54
Average Volume (20 Days)	1,067,125

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3176 had revenue of TWD 1.34 billion and -264.40 million in losses. Loss per share was -1.89.

Revenue	1.34B
Gross Profit	687.87M
Operating Income	-321.73M
Pretax Income	-393.20M
Net Income	-264.40M
EBITDA	-170.57M
EBIT	-321.73M
Loss Per Share	-1.89

Balance Sheet

The company has 2.85 billion in cash and 1.71 billion in debt, with a net cash position of 1.14 billion or 8.18 per share.

Cash & Cash Equivalents	2.85B
Total Debt	1.71B
Net Cash	1.14B
Net Cash Per Share	8.18
Equity (Book Value)	4.72B
Book Value Per Share	10.69
Working Capital	3.16B

Cash Flow

In the last 12 months, operating cash flow was -22.46 million and capital expenditures -165.25 million, giving a free cash flow of -187.71 million.

Operating Cash Flow	-22.46M
Capital Expenditures	-165.25M
Depreciation & Amortization	151.17M
Net Borrowing	705.37M
Free Cash Flow	-187.71M
FCF Per Share	-1.35

Margins

Gross margin is 51.16%, with operating and profit margins of -23.93% and -19.66%.

Gross Margin	51.16%
Operating Margin	-23.93%
Pretax Margin	-29.24%
Profit Margin	-19.66%
EBITDA Margin	-12.69%
EBIT Margin	-23.93%
FCF Margin	n/a

Dividends & Yields

TPEX:3176 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.38%
Shareholder Yield	-0.38%
Earnings Yield	-5.80%
FCF Yield	-4.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2